ANDREA MEYER: Open Payments
NPI 1831446962 · SOUTHBRIDGE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$896 in 34 payments from 11 companies in 2025. Trend: 2023 $241 · 2024 $579 · 2025 $896
Food & beverage: $896
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 14 | $311 |
| Amgen Inc. | 1 | $120 |
| E.R. Squibb & Sons, L.L.C. | 4 | $111 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $70 |
| BridgeBio Pharma, Inc. | 2 | $65 |
| SCPHARMACEUTICALS INC. | 3 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 1 | $32 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Actelion Pharmaceuticals US, Inc. | 1 | $26 |
Products named: VYNDAQEL, ELIQUIS, Repatha, Kerendia, Attruby, FUROSCIX, JARDIANCE, WAINUA.
Industry payments across MA — which companies pay providers there.
